|
|
|
|
|
|
|
|
|
|
9th Annual CPD Program Learning
Objectives
At the conclusion of this conference, attendees will:
• Understand PARP inhibitors and their potential role in ovarian cancer
treatment
• Review the role of chemotherapy before primary surgery and in
combination for recurrent ovarian cancer
• Learn about new innovations in cervical cancer treatment
• Review optimal thromboprophylaxis prior to gynecologic oncology surgery
• Evaluate recent literature on lymphadenectomy and chemotherapy in early
endometrial cancer
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.